Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid in weight loss. However, compounded versions of this drug have started to enter the market,

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.

Weight loss medication can be prescribed to people battling liver disease under new guidelines announced today.

Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that’s approved by the U.S. Food and Drug Administration (FDA) for type 2 diabetes.

Amid her return to the tennis court at Wimbledon 2026, Williams recently opened up about her year's-long weight loss journey discussing the drug that has her looking and feeling better than ever.